List of Tables

Table 1. Pelvic Congestion Syndrome Treatment Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Pelvic Congestion Syndrome Treatment Market Restraints

Table 3. Pelvic Congestion Syndrome Treatment Market Trends

Table 4. Pelvic Congestion Syndrome Treatment Industry Policy

Table 5. Global Pelvic Congestion Syndrome Treatment Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Pelvic Congestion Syndrome Treatment Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Pelvic Congestion Syndrome Treatment Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Pelvic Congestion Syndrome Treatment Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Pelvic Congestion Syndrome Treatment Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)

Table 10. Global Pelvic Congestion Syndrome Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Pelvic Congestion Syndrome Treatment Mergers & Acquisitions, Expansion Plans

Table 12. Global Pelvic Congestion Syndrome Treatment Manufacturers Product Type

Table 13. Head Office and Pelvic Congestion Syndrome Treatment Production Site of Key Manufacturer

Table 14. Pelvic Congestion Syndrome Treatment Capacity of Major Manufacturers and Future Plan

Table 15. China Pelvic Congestion Syndrome Treatment Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Pelvic Congestion Syndrome Treatment Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Pelvic Congestion Syndrome Treatment Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 18. China Pelvic Congestion Syndrome Treatment Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Pelvic Congestion Syndrome Treatment Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)

Table 20. Global Pelvic Congestion Syndrome Treatment Production by Region, 2020-2025, (K Units)

Table 21. Global Pelvic Congestion Syndrome Treatment Production Forecast by Region, 2026-2031, (K Units)

Table 22. Global Key Players of Pelvic Congestion Syndrome Treatment Upstream (Raw Materials)

Table 23. Global Pelvic Congestion Syndrome Treatment Typical Customers

Table 24. Pelvic Congestion Syndrome Treatment Typical Distributors

Table 25. by Type, Global Pelvic Congestion Syndrome Treatment Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Pelvic Congestion Syndrome Treatment Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Pelvic Congestion Syndrome Treatment Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Pelvic Congestion Syndrome Treatment Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Pelvic Congestion Syndrome Treatment Sales Quantity, 2020-2031, (K Units)

Table 30. By Country, Global Pelvic Congestion Syndrome Treatment Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Pelvic Congestion Syndrome Treatment Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Pelvic Congestion Syndrome Treatment Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Pelvic Congestion Syndrome Treatment Sales Quantity, 2020-2031, (K Units)

Table 34. By Country, Global Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2020-2031

Table 35. Sanofi Company Information, Head Office, Market Area, and Industry Position

Table 36. Sanofi Pelvic Congestion Syndrome Treatment Models, Specifications, and Application

Table 37. Sanofi Pelvic Congestion Syndrome Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 38. Sanofi Company Profile and Main Business

Table 39. Sanofi Recent Developments

Table 40. TOLMAR Company Information, Head Office, Market Area, and Industry Position

Table 41. TOLMAR Pelvic Congestion Syndrome Treatment Models, Specifications, and Application

Table 42. TOLMAR Pelvic Congestion Syndrome Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 43. TOLMAR Company Profile and Main Business

Table 44. TOLMAR Recent Developments

Table 45. Actiza Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 46. Actiza Pharmaceutical Pelvic Congestion Syndrome Treatment Models, Specifications, and Application

Table 47. Actiza Pharmaceutical Pelvic Congestion Syndrome Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 48. Actiza Pharmaceutical Company Profile and Main Business

Table 49. Actiza Pharmaceutical Recent Developments

Table 50. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 51. Pfizer Pelvic Congestion Syndrome Treatment Models, Specifications, and Application

Table 52. Pfizer Pelvic Congestion Syndrome Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 53. Pfizer Company Profile and Main Business

Table 54. Pfizer Recent Developments

Table 55. Debiopharm Group Company Information, Head Office, Market Area, and Industry Position

Table 56. Debiopharm Group Pelvic Congestion Syndrome Treatment Models, Specifications, and Application

Table 57. Debiopharm Group Pelvic Congestion Syndrome Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 58. Debiopharm Group Company Profile and Main Business

Table 59. Debiopharm Group Recent Developments

Table 60. AbbVie Company Information, Head Office, Market Area, and Industry Position

Table 61. AbbVie Pelvic Congestion Syndrome Treatment Models, Specifications, and Application

Table 62. AbbVie Pelvic Congestion Syndrome Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 63. AbbVie Company Profile and Main Business

Table 64. AbbVie Recent Developments

Table 65. AstraZeneca Company Information, Head Office, Market Area, and Industry Position

Table 66. AstraZeneca Pelvic Congestion Syndrome Treatment Models, Specifications, and Application

Table 67. AstraZeneca Pelvic Congestion Syndrome Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 68. AstraZeneca Company Profile and Main Business

Table 69. AstraZeneca Recent Developments

Table 70. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 71. Novartis Pelvic Congestion Syndrome Treatment Models, Specifications, and Application

Table 72. Novartis Pelvic Congestion Syndrome Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 73. Novartis Company Profile and Main Business

Table 74. Novartis Recent Developments

Table 75. Indivior Company Information, Head Office, Market Area, and Industry Position

Table 76. Indivior Pelvic Congestion Syndrome Treatment Models, Specifications, and Application

Table 77. Indivior Pelvic Congestion Syndrome Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 78. Indivior Company Profile and Main Business

Table 79. Indivior Recent Developments

Table 80. Johnson and Johnson Company Information, Head Office, Market Area, and Industry Position

Table 81. Johnson and Johnson Pelvic Congestion Syndrome Treatment Models, Specifications, and Application

Table 82. Johnson and Johnson Pelvic Congestion Syndrome Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 83. Johnson and Johnson Company Profile and Main Business

Table 84. Johnson and Johnson Recent Developments

Table 85. Fresenius Kabi Company Information, Head Office, Market Area, and Industry Position

Table 86. Fresenius Kabi Pelvic Congestion Syndrome Treatment Models, Specifications, and Application

Table 87. Fresenius Kabi Pelvic Congestion Syndrome Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 88. Fresenius Kabi Company Profile and Main Business

Table 89. Fresenius Kabi Recent Developments

Table 90. TerSera Therapeutics Company Information, Head Office, Market Area, and Industry Position

Table 91. TerSera Therapeutics Pelvic Congestion Syndrome Treatment Models, Specifications, and Application

Table 92. TerSera Therapeutics Pelvic Congestion Syndrome Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 93. TerSera Therapeutics Company Profile and Main Business

Table 94. TerSera Therapeutics Recent Developments

Table 95. Takeda Company Information, Head Office, Market Area, and Industry Position

Table 96. Takeda Pelvic Congestion Syndrome Treatment Models, Specifications, and Application

Table 97. Takeda Pelvic Congestion Syndrome Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 98. Takeda Company Profile and Main Business

Table 99. Takeda Recent Developments

Table 100. Ferring Company Information, Head Office, Market Area, and Industry Position

Table 101. Ferring Pelvic Congestion Syndrome Treatment Models, Specifications, and Application

Table 102. Ferring Pelvic Congestion Syndrome Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 103. Ferring Company Profile and Main Business

Table 104. Ferring Recent Developments

List of Figures

Figure 1. Pelvic Congestion Syndrome Treatment Picture

Figure 2. Global Pelvic Congestion Syndrome Treatment Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Pelvic Congestion Syndrome Treatment Sales Quantity, (K Units) & (2020-2031)

Figure 4. Global Pelvic Congestion Syndrome Treatment Average Selling Price (ASP), (2020-2031) & (US$/Unit)

Figure 5. China Pelvic Congestion Syndrome Treatment Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Pelvic Congestion Syndrome Treatment Sales Quantity (K Units) & (2020-2031)

Figure 7. China Pelvic Congestion Syndrome Treatment Average Selling Price (ASP), (US$/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Pelvic Congestion Syndrome Treatment Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Pelvic Congestion Syndrome Treatment Market Share of Global, 2020-2031

Figure 10. Global Pelvic Congestion Syndrome Treatment Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Pelvic Congestion Syndrome Treatment Key Participants, Market Share, 2024

Figure 12. Global Pelvic Congestion Syndrome Treatment Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Pelvic Congestion Syndrome Treatment Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Pelvic Congestion Syndrome Treatment Production Market Share & Forecast by Region, 2020-2031

Figure 15. Pelvic Congestion Syndrome Treatment Industry Chain

Figure 16. Pelvic Congestion Syndrome Treatment Procurement Model

Figure 17. Pelvic Congestion Syndrome Treatment Sales Model

Figure 18. Pelvic Congestion Syndrome Treatment Sales Channels, Direct Sales, and Distribution

Figure 19. NSAIDs (Nonsteroidal Anti-Inflammatory Drugs)

Figure 20. Dihydroergotamine

Figure 21. Progestins

Figure 22. Others

Figure 23. by Type, Global Pelvic Congestion Syndrome Treatment Consumption Value, 2020-2031, US$ Million

Figure 24. by Type, Global Pelvic Congestion Syndrome Treatment Consumption Value Market Share, 2020-2031

Figure 25. by Type, Global Pelvic Congestion Syndrome Treatment Sales Quantity, 2020-2031, (K Units)

Figure 26. by Type, Global Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2020-2031

Figure 27. by Type, Global Pelvic Congestion Syndrome Treatment Average Selling Price (ASP), 2020-2031, (US$/Unit)

Figure 28. Primary Pelvic Congestion Syndrome

Figure 29. Secondary Pelvic Congestion Syndrome

Figure 30. by Application, Global Pelvic Congestion Syndrome Treatment Consumption Value, 2020-2031, US$ Million

Figure 31. by Application, Global Pelvic Congestion Syndrome Treatment Revenue Market Share, 2020-2031

Figure 32. by Application, Global Pelvic Congestion Syndrome Treatment Sales Quantity, 2020-2031, (K Units)

Figure 33. by Application, Global Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2020-2031

Figure 34. by Application, Global Pelvic Congestion Syndrome Treatment Price, 2020-2031, (US$/Unit)

Figure 35. By Region, Global Pelvic Congestion Syndrome Treatment Consumption Value Market Share, 2020-2031

Figure 36. By Region, Global Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2020-2031

Figure 37. North America Pelvic Congestion Syndrome Treatment Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 38. By Country, North America Pelvic Congestion Syndrome Treatment Consumption Value Market Share, 2024

Figure 39. Europe Pelvic Congestion Syndrome Treatment Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 40. By Country, Europe Pelvic Congestion Syndrome Treatment Consumption Value Market Share, 2024

Figure 41. Asia Pacific Pelvic Congestion Syndrome Treatment Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 42. By Country/Region, Asia Pacific Pelvic Congestion Syndrome Treatment Consumption Value Market Share, 2024

Figure 43. South America Pelvic Congestion Syndrome Treatment Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 44. By Country, South America Pelvic Congestion Syndrome Treatment Consumption Value Market Share, 2024

Figure 45. Middle East & Africa Pelvic Congestion Syndrome Treatment Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 46. United States Pelvic Congestion Syndrome Treatment Sales Quantity, 2020-2031, (K Units)

Figure 47. by Type, United States Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 48. by Application, United States Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 49. Europe Pelvic Congestion Syndrome Treatment Sales Quantity, 2020-2031, (K Units)

Figure 50. by Type, Europe Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 51. by Application, Europe Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 52. China Pelvic Congestion Syndrome Treatment Sales Quantity, 2020-2031, (K Units)

Figure 53. by Type, China Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 54. by Application, China Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 55. Japan Pelvic Congestion Syndrome Treatment Sales Quantity, 2020-2031, (K Units)

Figure 56. by Type, Japan Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 57. by Application, Japan Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 58. South Korea Pelvic Congestion Syndrome Treatment Sales Quantity, 2020-2031, (K Units)

Figure 59. by Type, South Korea Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 60. by Application, South Korea Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 61. Southeast Asia Pelvic Congestion Syndrome Treatment Sales Quantity, 2020-2031, (K Units)

Figure 62. by Type, Southeast Asia Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 63. by Application, Southeast Asia Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 64. India Pelvic Congestion Syndrome Treatment Sales Quantity, 2020-2031, (K Units)

Figure 65. by Type, India Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 66. by Application, India Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 67. Middle East & Africa Pelvic Congestion Syndrome Treatment Sales Quantity, 2020-2031, (K Units)

Figure 68. by Type, Middle East & Africa Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 69. by Application, Middle East & Africa Pelvic Congestion Syndrome Treatment Sales Quantity Market Share, 2024 VS 2031

Figure 70. Research Methodology

Figure 71. Breakdown of Primary Interviews

Figure 72. Bottom-up Approaches

Figure 73. Top-down Approaches